HB1667

Requires health benefit plans and prescription drug programs to use manufacturer copay assistance to reduce patient costs.

Mississippi HB1667 mandates that health benefit plans and prescription drug programs receiving manufacturer copay assistance must apply the value of this assistance to reduce or limit the amount a patient pays for a prescription drug and/or apply it to a patient's annual cost-sharing requirements, such as deductibles and out-of-pocket maximum costs. The bill aims to ensure that copay assistance directly benefits patients by lowering their prescription drug costs and annual cost-sharing requirements.